Black Rock Inc. Cytom X Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 1,139,029 shares of CTMX stock, worth $888,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,139,029

Previous 1,131,208 0.69%

Holding current value

$888,442

Previous $2.47 Million 43.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.21 - $5.13 $9,463 - $40,121	7,821 Added 0.69%	1,139,029 $1.39 Million
Q1 2024 May 10, 2024	SELL	$1.41 - $2.74 $6,947 - $13,499	-4,927 Reduced 0.43%	1,131,208 $2.47 Million
Q4 2023 Feb 13, 2024	SELL	$1.07 - $1.55 $3,746 - $5,426	-3,501 Reduced 0.31%	1,136,135 $1.76 Million
Q3 2023 Nov 13, 2023	SELL	$1.26 - $1.87 $10,306 - $15,296	-8,180 Reduced 0.71%	1,139,636 $1.47 Million
Q2 2023 Aug 11, 2023	BUY	$1.41 - $1.92 $33,902 - $46,164	24,044 Added 2.14%	1,147,816 $1.97 Million
Q1 2023 May 12, 2023	SELL	$1.48 - $2.88 $260,818 - $507,539	-176,229 Reduced 13.56%	1,123,772 $1.7 Million
Q4 2022 Feb 13, 2023	SELL	$1.19 - $1.91 $594,240 - $953,781	-499,362 Reduced 27.75%	1,300,001 $2.08 Million
Q3 2022 Nov 14, 2022	SELL	$1.23 - $1.97 $33,490 - $53,639	-27,228 Reduced 1.49%	1,799,363 $2.61 Million
Q2 2022 Aug 12, 2022	SELL	$1.53 - $2.89 $4.84 Million - $9.15 Million	-3,165,503 Reduced 63.41%	1,826,591 $3.34 Million
Q1 2022 May 12, 2022	BUY	$2.67 - $4.68 $79,384 - $139,145	29,732 Added 0.6%	4,992,094 $13.3 Million
Q4 2021 Feb 10, 2022	SELL	$3.87 - $7.39 $349,224 - $666,866	-90,239 Reduced 1.79%	4,962,362 $21.5 Million
Q3 2021 Nov 09, 2021	SELL	$4.32 - $6.43 $121,055 - $180,181	-28,022 Reduced 0.55%	5,052,601 $25.7 Million
Q2 2021 Aug 11, 2021	BUY	$6.33 - $9.91 $32.2 Million - $50.3 Million	5,080,623 New	5,080,623 $32.2 Million

Others Institutions Holding CTMX

# of Institutions

Shares Held

46.1M

Call Options Held

3.7K

Put Options Held

4.7K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $51.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account